Related references
Note: Only part of the references are listed.Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms
Bianca N. Mason et al.
JOURNAL OF NEUROSCIENCE (2017)
A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure
Aisah A. Aubdool et al.
CIRCULATION (2017)
CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1
Keegan J. Bohn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Assessing bioequivalence of generic modified-release antiepileptic drugs
Emily L. Johnson et al.
NEUROLOGY (2016)
NEUROVASCULAR CONTRIBUTIONS TO MIGRAINE: MOVING BEYOND VASODILATION
Blaine Jacobs et al.
NEUROSCIENCE (2016)
Exercise prevents development of autonomic dysregulation and hyperalgesia in a mouse model of chronic muscle pain
Rasna Sabharwal et al.
PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
CGRP as a neuropeptide in migraine: lessons from mice
Andrew F. Russo
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
An Ongoing Role of α-Calcitonin Gene-Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
Sarah-Jane Smillie et al.
HYPERTENSION (2014)
Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure
Tu H. Mai et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
Vasodilation out of the picture as a cause of migraine headache
Andrew Charles
LANCET NEUROLOGY (2013)
Migraine and Hemorrhagic Stroke A Meta-analysis
Simona Sacco et al.
STROKE (2013)
Vascular changes have a primary role in migraine
Messoud Ashina
CEPHALALGIA (2012)
Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice
Zhongming Zhang et al.
DIABETES (2011)
The Extracranial Vascular Theory of Migraine-A Great Story Confirmed by the Facts
Elliot Shevel
HEADACHE (2011)
Sex Matters: Evaluating Sex and Gender in Migraine and Headache Research
B. Lee Peterlin et al.
HEADACHE (2011)
Expression profiles of nestin in vascular smooth muscle cells in vivo and in vitro
Hiroki Oikawa et al.
EXPERIMENTAL CELL RESEARCH (2010)
Receptor Activity-Modifying Protein 1 Increases Baroreflex Sensitivity and Attenuates Angiotensin-Induced Hypertension
Rasna Sabharwal et al.
HYPERTENSION (2010)
Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain
Jakob S. Satz et al.
JOURNAL OF NEUROSCIENCE (2010)
Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP
Ana Recober et al.
NEUROPHARMACOLOGY (2010)
Receptor Activity-Modifying Protein-1 Augments Cerebrovascular Responses to Calcitonin Gene-Related Peptide and Inhibits Angiotensin II-Induced Vascular Dysfunction
Sophocles Chrissobolis et al.
STROKE (2010)
The vascular theory of migrainea great story wrecked by the facts
Peter J. Goadsby
BRAIN (2009)
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Ana Recober et al.
JOURNAL OF NEUROSCIENCE (2009)
Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice
Blanca Marquez de Prado et al.
JOURNAL OF PAIN (2009)
Migraine and cardiovascular disease: systematic review and meta-analysis
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactlivity in the rat trigeminovascular system:: Differences between peripheral and central CGRP receptor distribution
Jochen K. Lennerz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Heart rate variability in mice: a theoretical and practical guide
J. Thireau et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Hypertension and dysregulated proinflarnmatory cytokine production in receptor activity-modifying protein 1-deficient mice
Kazutake Tsujikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/IoxP mediated recombination in the nervous system, kidney, and somite-derived tissues
Nicole C. Dubois et al.
GENESIS (2006)
Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells
ZM Zhang et al.
ENDOCRINOLOGY (2006)
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies
M Etminan et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Development of angiotensin II-induced hypertension: role of CGRP and its receptor
JP Li et al.
JOURNAL OF HYPERTENSION (2005)
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system
MC Zimmerman et al.
CIRCULATION RESEARCH (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP
YP Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Baroreflex buffering and susceptibility to vasoactive drugs
J Jordan et al.
CIRCULATION (2002)
Elevated sympathetic nervous activity in mice deficient in αCGRP
Y Oh-hashi et al.
CIRCULATION RESEARCH (2001)
β1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex
D Graus-Porta et al.
NEURON (2001)
Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice
PRR Gangula et al.
HYPERTENSION (2000)
Share Paper
